Exhibit 99.1
|
Craig Colosso Relationship Management |
|
|
American Stock Transfer & Trust Company, LLC |
|
March 12, 2021
|
Alberta Securities Commission |
|
British Columbia Securities Commission |
|
Ontario Securities Commission |
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
|
Date of meeting: |
June 3, 2021 |
|
Record date for notice: |
April 8, 2021 |
|
Record date for voting: |
April 8, 2021 |
|
Beneficial ownership determination date: |
April 8, 2021 |
|
Securities entitled to notice: |
Common Shares and Series 1 Preferred Shares |
|
Securities entitled to vote: |
Common Shares and Series 1 Preferred Shares |
|
Issuer mailing directly to non objecting beneficial owners: |
No |
|
Issuer will pay for objecting beneficial owner material distribution: |
Yes |
|
Issuer using notice-and-access for registered investors: |
No |
|
Issuer using notice-and-access for non-registered investors: |
No |
|
Notice-and-access stratification criteria: |
N/A |
Yours very truly,
/s/ Craig Colosso
Craig Colosso
Relationship Manager
American Stock Transfer & Trust Company, LLC